Debbie's Place

A Patient's Point of View

CBR – GPR55/ CB3 CANNABINOID RECEPTOR

CBR – GPR55/ CB3 CANNABINOID RECEPTOR

Activated by l-α-lysophosphatidylinositol (LPI), and to a lesser extent possibly by THC, CBD,O-1602, PEA, 2-AG, Anandamide, Virodhamine

 

Cannabinoid Receptor Ligands                    (full – undated)

http://www.tocris.com/pdfs/cannabinoid_receptor_review/page_001.html

 

Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. (abst – 1999)         http://www.ncbi.nlm.nih.gov/pubmed/9931487

 

Evolutionary Origins of the Endocannabinoid System.                    (abst – 2006)

http://www.ncbi.nlm.nih.gov/pubmed/16434153

 

GPR55: a new member of the cannabinoid receptor clan?                     (full – 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095104/?tool=pubmed

 

The orphan receptor GPR55 is a novel cannabinoid receptor.   (full – 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095107/?tool=pubmed

 

GPR55 and the vascular receptors for cannabinoids.                      (full – 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190021/?tool=pubmed

 

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.                                                        (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190033/?tool=pubmed

 

GPR55 and the vascular receptors for cannabinoids.                    (full – 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190021/?tool=pubmed

 

GPR55 is a novel cannabinoid receptor                   (full – 2007)

http://www.biomedcentral.com/1471-2210/7/S2/A3

 

Novel cannabinoid receptors                     (full – 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190013/?tool=pmcentrez

 

GPR55: signaling pathways and functions                    (abst – 2007)

http://www.biomedcentral.com/1471-2210/9/S2/A3

 

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current          (full – 2008)                                http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268199/?tool=pubmed

 

 

 

 

 

 

 

 

 

Interactions of the G protein-coupled receptor-associated sorting proteins (GASP) 1 and 2 with the novel cannabinoid receptor GPR55                                        (abst – 2008)  http://www.biomedcentral.com/1471-2210/8/S1/A16

 

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo       (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737440/?tool=pubmed

 

Receptors for acylethanolamides-GPR55 and GPR119.              (full – 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751869/?tool=pubmed

 

Endocannabinoid-mediated control of synaptic transmission.             (full – 2009)

http://physrev.physiology.org/content/89/1/309.long

 

The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.                                              (full – 2009)     http://www.fasebj.org/content/23/1/183.long

 

Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. (full – 2009)

http://www.jbc.org/content/284/43/29817.full?sid=ec54c280-2526-4d1b-ab9f-73a1ca683a5e

 

Is GPR55 an anandamide receptor?             (abst – 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19647110

 

Receptors for acylethanolamides-GPR55 and GPR119.               (full – 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751869/?tool=pubmed

 

The enigmatic pharmacology of GPR55.              (abst – 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19233486.

 

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2                                                             (full – 2010)  http://pharmrev.aspetjournals.org/content/62/4/588.full.pdf+html

 

GPR55 ligands promote receptor coupling to multiple signalling pathways.   (full – 2010)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931561/?tool=pubmed

 

Pharmacological characterization of GPR55, a putative cannabinoid receptor. (abst – 2010)

http://www.unboundmedicine.com/medline/ebm/record/20298715/abstract/Pharmacological_characteriza       ti  on_of_GPR55_a_putative_cannabinoid_receptor_

 

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment.                                                    (abst – 2010)        http://www.ncbi.nlm.nih.gov/pubmed/21080464

 

GPR55: Current Knowledge and Future Perspectives of a Purported “Type-3” Cannabinoid Receptor.    (abst – 2010)                                           http://www.ncbi.nlm.nih.gov/pubmed/20166924

 

Cannabinoids and the gut: new developments and emerging concepts              (abst – 2010)

 

 

 

 

 

 

 

 

http://www.ncbi.nlm.nih.gov/pubmed/20117132

 

A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells.                                                             (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20590578

 

Cannabinoids and Bone: Friend or Foe?               (abst – 2010)

http://www.ncbi.nlm.nih.gov/pubmed/20532878

 

Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator. (abst – 2010)                                           http://www.ncbi.nlm.nih.gov/pubmed/20649563

 

Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist.                                            (full – 2011)  http://jpet.aspetjournals.org/content/337/1/236.long

 

Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55.  (full – 2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086297/?tool=pubmed

 

Screening for Selective Ligands for GPR55.            (full – 2011)

http://www.ncbi.nlm.nih.gov/books/NBK66153/

 

New blood brothers: the GPR55 and CB2 partnership                (full – 2011)

http://www.nature.com/cr/journal/vaop/ncurrent/full/cr201177a.html

 

A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. (full – 2011)                                  http://joe.endocrinology-journals.org/content/211/2/177.long

 

Pharmacology of GPR55 in Yeast and Identification of GSK494581A as a Mixed- Activity Glycine Transporter Subtype 1 Inhibitor and GPR55 Agonist                                                              (full – 201)  http://jpet.aspetjournals.org/content/337/1/236.full?sid=97274573-5add-46c8-9e15-6b3fe448e8c4

 

A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells.                                                              (full – 2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931574/?tool=pubmed

 

L-α-lysophosphatidylinositol meets GPR55: a deadly relationship.                (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21367464

 

What is the natural ligand of GPR55?                (abst – 2011)

http://jb.oxfordjournals.org/content/149/5/495.short?rss=1

 

Pharmacology, Signaling and Physiological Relevance of the G Protein-coupled Receptor

55.   (abst – 2011)              http://www.ncbi.nlm.nih.gov/pubmed/21907912

 

GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils. (abst – 2011)

 

 

 

 

 

 

 

 

http://www.unboundmedicine.com/medline/ebm/record/21467997/abstract/GPR55_regulates_cannabinoid_ 2_receptor_mediated_responses_in_human_neutrophils_

 

The GPCR – associated sorting protein 1 regulates ligand-induced downregulation of GPR55.     (abst – 2011)                            http://www.ncbi.nlm.nih.gov/pubmed/21718301

 

Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor.                                                 (abst – 2011)         http://www.ncbi.nlm.nih.gov/pubmed/21464819

 

The novel cannabinoid receptor GPR55, inhibits cholangiocarcinoma growth (abst – 2011)

http://www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/1117.3?maxtoshow=&hits=80

&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcety  pe=HWCIT

 

Modulation of the novel cannabinoid receptor – GPR55 – during rat fetoplacental development    (abst – 2011)                                    http://www.ncbi.nlm.nih.gov/pubmed/21497900

 

A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents.        (abst – 2011)                     http://www.ncbi.nlm.nih.gov/pubmed/21726355

 

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment.                                                   (abst – 2011)         http://www.ncbi.nlm.nih.gov/pubmed/21744421

 

The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55.                                                     (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21683763

 

Pharmacology, signaling and physiological relevance of the G protein-coupled receptor

55.               (abst – 2011)          http://www.ncbi.nlm.nih.gov/pubmed/21907912

 

Functional polymorphism in the GPR55 gene is associated with anorexia nervosa. (abst – 2011)                                     http://www.ncbi.nlm.nih.gov/pubmed/20506567

 

The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation.       (abst – 2011)                       http://www.ncbi.nlm.nih.gov/pubmed/20838378

 

Off-Target Cannabinoid Effects Mediated by GPR55.               (full – 2012)

http://content.karger.com/produktedb/produkte.asp?DOI=000336872&typ=pdf

 

Role of cannabinoids in the regulation of bone remodeling  (full – 2012)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499879/

 

The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity. (full – 2012)                                      http://diabetes.diabetesjournals.org/content/61/2/281.long

 

The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.   (full – 2012)

 

 

 

 

 

 

 

 

http://www.jbc.org/content/early/2012/11/16/jbc.M112.364109.long

 

The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain.                                                                     (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22227298

 

The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55.                                                            (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22454039

 

Effects of Palmitoylethanolamide on Aqueous Humor Outflow.                 (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22589443

 

The interaction between intrathecal administration of low doses of  palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats.      (abst – 2012)                                                                  http://www.ncbi.nlm.nih.gov/pubmed/22201038

 

Evidence for the Putative Cannabinoid Receptor (GPR55)-Mediated Inhibitory Effects on Intestinal Contractility in Mice.   (abst – 2012)                                                       http://www.ncbi.nlm.nih.gov/pubmed/22759743

 

GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors. (abst – 2012)                                          http://www.ncbi.nlm.nih.gov/pubmed/22820167

 

A potential role for GPR55 in gastrointestinal functions.                    (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/23063456

 

The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55                                                              (abst – 2012)  http://link.springer.com/article/10.1007%2Fs11481-012-9351-6#page-1

 

A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55.

(abst – 2012)                   http://www.ncbi.nlm.nih.gov/pubmed/23220281

 

Share a link for

1 Comment

  1. I think the admin of this web page is truly working hard in favor of his web site, for the reason that here every stuff is quality based stuff.

Leave a Reply

Your email address will not be published.

*

© 2019 Debbie's Place

Powered by

www.420.ag